[Community-acquired Pseudomonas stutzeri meningitis in an immunocompetent patient]

Mustafa Sünbül1, Muammer Zivalioğlu, Nuriye Taşdelen Fişgin

  • 1Ondokuz Mayis Universitesi Tip Fakültesi, Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Anabilim Dali, Samsun. msunbul@omu.edu.tr

Mikrobiyoloji Bulteni
|April 2, 2009
PubMed

Insights

A rare case of community-acquired bacterial meningitis caused by Pseudomonas stutzeri in an elderly male highlights the potential for uncommon pathogens to cause severe infections. Empirical treatment may fail, underscoring the need for vigilance in diagnosing unusual meningitis cases.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Neurology

Background:

  • Pseudomonas stutzeri is an aerobic, gram-negative bacillus commonly found in environmental settings.
  • This bacterium rarely causes serious community-acquired infections, including meningitis.

Observation:

  • A 73-year-old male presented with symptoms of acute bacterial meningitis, including altered mental status and nuchal rigidity.
  • Cerebrospinal fluid analysis revealed low glucose, high protein, and a significant white blood cell count with a predominance of neutrophils.
  • Initial Gram stain of cerebrospinal fluid was negative for bacteria.

Findings:

  • Despite empirical treatment with ceftriaxone and ampicillin, the patient expired 16 hours after admission.
  • Cerebrospinal fluid culture identified the causative agent as Pseudomonas stutzeri.
  • The isolated Pseudomonas stutzeri strain demonstrated susceptibility to a range of antibiotics, including piperacillin/tazobactam, aminoglycosides, cephalosporins, carbapenems, and fluoroquinolones.

Implications:

  • This case underscores that uncommon bacteria like Pseudomonas stutzeri can cause severe community-acquired meningitis, particularly in elderly individuals.
  • Empirical treatment strategies for bacterial meningitis may be inadequate against rare pathogens, potentially leading to high morbidity and mortality.
  • Clinicians should consider a broader spectrum of potential pathogens when managing meningitis in vulnerable populations, especially when initial diagnostic tests are inconclusive.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...